Equity Details
Price & Market Data
Price: $0.204
Daily Change: -$0.0081 / 3.97%
Daily Range: $0.20 - $0.228
Market Cap: $3,301,638
Daily Volume: 543,548
Performance Metrics
1 Week: 9.95%
1 Month: -2.72%
3 Months: 15.44%
6 Months: -33.27%
1 Year: -89.09%
YTD: -20.08%
About Azitra, Inc. (AZTR)
Stay updated on Azitra, Inc. (AZTR). Price: 0.204, daily change: -$0.0081 / 3.97%. Market cap: 3,301,638. Performance YTD, 1-week, and 52-week are key.
Company Details
Employees: 13
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease. It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut.
